Alzheimer’s Disease Linked Brain Insulin Resistance Clarified
Defects in insulin receptors at the blood–brain barrier contribute to brain insulin resistance and affect β-amyloid pathology in Alzheimer’s disease (AD), a study published on Tuesday reports. The study clarifies the mechanisms of insulin activity in microvessels of the brain and provides evidence of insulin resistance at the level of the blood-brain barrier. The findings supporting the idea that AD is a neurodegenerative disease with a strong metabolic component and may expand the range of drugs that could be tested for AD.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed